SomnoMed Limited (ASX:SOM) Insider Purchases A$10,749.06 in Stock

Posted by on Sep 10th, 2024

SomnoMed Limited (ASX:SOM – Get Free Report) insider Karen Borg bought 25,593 shares of the firm’s stock in a transaction on Monday, September 9th. The stock was purchased at an average cost of A$0.42 ($0.28) per share, with a total value of A$10,749.06 ($7,166.04).

SomnoMed Price Performance

The company has a current ratio of 1.76, a quick ratio of 1.05 and a debt-to-equity ratio of 14.93.

About SomnoMed

(Get Free Report)

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea.

Read More

Receive News & Ratings for SomnoMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SomnoMed and related companies with MarketBeat.com's FREE daily email newsletter.